C.J. is the portfolio manager for the Global Healthcare Strategy and provides fundamental research on the healthcare sector for the capital appreciation team. He has expertise within global therapeutics, including biotechnology, pharmaceuticals, specialty pharmaceuticals, and generics. Before joining the firm, C.J. was a senior healthcare analyst at Fred Alger Management. Other prior roles included an analyst supporting long/short healthcare portfolios at Catapult and at Lombard Odier, and he was also co-director of research and the executive director and lead analyst with the healthcare group at UBS Wealth Management. C.J. started his career at UBS Investment Bank as a pharmaceutical analyst in the U.S. equity research division.

• Education: B.S. in Biology, Bucknell University; M.S. in Neurobiology/Physiology, The College of William and Mary
• Joined company: 2020
• Began career: 1997